MAPT and Alzheimer disease: Specifically, Swiss individuals that mapped to Subtype 3 exhibited low Aβ levels, consistent with AD‐like Subtypes 4, 5, and 6, while their tau levels aligned more closely with the control‐like Subtypes 1 and 2 (Figure 5C).